<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02986204</url>
  </required_header>
  <id_info>
    <org_study_id>version 1.0 07/25/16</org_study_id>
    <nct_id>NCT02986204</nct_id>
  </id_info>
  <brief_title>Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant</brief_title>
  <acronym>ENG</acronym>
  <official_title>Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate in-office ultrasound localization vs localization in radiology&#xD;
      for identification and removal of non palpable etonogestrel (ENG) contraceptive implants and&#xD;
      aims to help establish best practices in this domain. Investigators will also create an&#xD;
      ultrasound image gallery of palpable and non palpable as well as instructional video for non&#xD;
      palpable ENG implant removal.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a descriptive study to establish best practices for ENG implant localization and&#xD;
      non-palpable ENG implant removal.&#xD;
&#xD;
      Women presenting to UCLA Obstetrics and Gynecology service for ENG non-palpable and palpable&#xD;
      implant removal or with ENG implant in place but desiring continuation will be enrolled.&#xD;
      Investigators aim to enroll 20 women in each group. Screening data will be reviewed to&#xD;
      determine subject eligibility. Subjects who meet all inclusion criteria will be entered into&#xD;
      the study.&#xD;
&#xD;
      Study duration for each participant is one visit for continuation group and two weeks for&#xD;
      group desiring implant removal. Total study duration is expected to be 18 months.&#xD;
&#xD;
        1. For women desiring implant removal: document ENG implant using in-office imaging of ENG&#xD;
           implant in the FP clinic with standard ob/gyn office ultrasound (abdominal 15 MHz linear&#xD;
           probe with color doppler) and the same, using high frequency vascular probe (20+ MHz) in&#xD;
           the radiology department.&#xD;
&#xD;
        2. Create an image gallery of office and radiology department obtained images of ENG&#xD;
           implant localization. This will include:&#xD;
&#xD;
             1. Ultrasound images obtained in women with palpable or non-palpable ENG implants in&#xD;
                place at various time intervals after insertion who desire ENG implant continuation&#xD;
                (office imaging only).&#xD;
&#xD;
             2. Ultrasound images obtained in women seeking removal of non-palpable ENG implants,&#xD;
                primarily referred patients who have either failed outside implant removal or have&#xD;
                a non-palpable implant on presentation for removal.&#xD;
&#xD;
        3. Document and describe all cases of non palpable ENG implant removal with standard,&#xD;
           in-office US versus radiology ultrasound equipment. Investigators will collect&#xD;
           radiographic images, clinical findings, instruments used, patient characteristics (BMI,&#xD;
           weight gain, time since of insertion), success of procedure, duration of procedure,&#xD;
           number of attempts, final location of implant, and need for referral to general or&#xD;
           vascular surgeon.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Actual">May 2020</completion_date>
  <primary_completion_date type="Actual">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Creation of image gallery</measure>
    <time_frame>18 months</time_frame>
    <description>Creating an image gallery in order to locate ENG implant using ultrasound and radiological images</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Creation of an instructional video and reference guide for ENG implant removal.</measure>
    <time_frame>18 months</time_frame>
    <description>If ultrasound/radiological images are successful at locating ENG implant, this data could lead to the creation of a reference guide for other providers.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Women With an ENG Contraceptive Implant</condition>
  <arm_group>
    <arm_group_label>removal of ENG implant group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>20 women who have an ENG implant that is difficult to feel on exam and would like to have it removed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>continuation of ENG implant</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>20 women who have are continuing to use their ENG implant.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>removal of ENG implant</intervention_name>
    <description>the researcher(s) will ask you to: Visit 1 - SCREENING VISIT&#xD;
questions about your medical/contraception history&#xD;
Review medical record&#xD;
physical examination&#xD;
urine sample for pregnancy test&#xD;
Visit 2a - Radiology&#xD;
Have an ultrasound of your arm&#xD;
The radiologist will mark your arm at the location of the implant.&#xD;
Visit 2b&#xD;
ultrasound of your arm to locate the implant. This is done by feeling the area.&#xD;
Have your ENG implant removed through a numbed small cut. The researcher will apply a pressure bandage to the site(s). This will reduce bleeding/decrease swelling.&#xD;
Have the removal procedure video recorded.&#xD;
Visit 3 - FOLLOW UP VISIT approximately 2 weeks after Visit 2:&#xD;
Provide a urine sample for pregnancy test&#xD;
Have the implant removal site examined</description>
    <arm_group_label>removal of ENG implant group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continuation of ING implant</intervention_name>
    <description>the researcher(s) will ask you to:&#xD;
To answer questions about your medical and contraception history&#xD;
Review your medical record&#xD;
Have a physical examination by the researcher&#xD;
Provide a urine sample for pregnancy test&#xD;
Have an ultrasound of your arm</description>
    <arm_group_label>continuation of ENG implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women age 18 - 50 years old&#xD;
&#xD;
          -  English or Spanish speaking&#xD;
&#xD;
          -  ENG implant in place&#xD;
&#xD;
          -  Removal group&#xD;
&#xD;
             o Women with non palpable ENG implant desiring ENG implant removal&#xD;
&#xD;
          -  Continuation group o Women with palpable or non-palpable ENG implant desiring&#xD;
             continuation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known or suspected pregnancy&#xD;
&#xD;
          -  Does not meet inclusion criteria&#xD;
&#xD;
          -  Known ENG implant location outside of arm&#xD;
&#xD;
          -  Current anticoagulation use (removal group only)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>UCLA Dept. OB/GYN Div. of Family Planning</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCLA Dept. OB/GYN, Women's Health CRU, 10833 Le Conte Ave, CHS 22-265</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mommers E, Blum GF, Gent TG, Peters KP, SÃ¸rdal TS, Marintcheva-Petrova M. Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial. Am J Obstet Gynecol. 2012 Nov;207(5):388.e1-6. doi: 10.1016/j.ajog.2012.08.002. Epub 2012 Aug 10.</citation>
    <PMID>22939402</PMID>
  </reference>
  <reference>
    <citation>Pillai M, Gazet AC, Griffiths M. Continuing need for and provision of a service for non-standard implant removal. J Fam Plann Reprod Health Care. 2014 Apr;40(2):126-32. doi: 10.1136/jfprhc-2013-100619. Epub 2013 Sep 30.</citation>
    <PMID>24081828</PMID>
  </reference>
  <reference>
    <citation>Guiahi M, Tocce K, Teal S, Green T, Rochon P. Removal of a Nexplanon implant located in the biceps muscle using a combination of ultrasound and fluoroscopy guidance. Contraception. 2014 Dec;90(6):606-8. doi: 10.1016/j.contraception.2014.06.030. Epub 2014 Jun 27.</citation>
    <PMID>25081861</PMID>
  </reference>
  <reference>
    <citation>Chen MJ, Creinin MD. Removal of a Nonpalpable Etonogestrel Implant With Preprocedure Ultrasonography and Modified Vasectomy Clamp. Obstet Gynecol. 2015 Nov;126(5):935-938. doi: 10.1097/AOG.0000000000001082.</citation>
    <PMID>26444124</PMID>
  </reference>
  <reference>
    <citation>Singh M, Mansour D, Richardson D. Location and removal of non-palpable Implanon implants with the aid of ultrasound guidance. J Fam Plann Reprod Health Care. 2006 Jul;32(3):153-6.</citation>
    <PMID>16857066</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 2, 2016</study_first_submitted>
  <study_first_submitted_qc>December 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2016</study_first_posted>
  <last_update_submitted>April 28, 2021</last_update_submitted>
  <last_update_submitted_qc>April 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Angela Chen, MD</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>implant removal</keyword>
  <keyword>Nexplanon</keyword>
  <keyword>Implanon</keyword>
  <keyword>contraception</keyword>
  <keyword>ENG</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

